...
首页> 外文期刊>Oncogene >Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16|[sol]|18-infected cancer cells
【24h】

Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16|[sol]|18-infected cancer cells

机译:通过下调人乳头瘤病毒16 | [sol] | 18感染癌细胞中的细胞周期蛋白B1来恢复抑癌p53

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abrogation of functional p53 is responsible for malignant cell transformation and the maintenance of malignant state of human papillomavirus-infected cancer cells. Thus, restoration of p53 has been regarded as an important strategy for molecular intervention combating papillomavirus-associated malignancies. We show here that depleting cyclin B1 stabilizes and reactivates p53 in papillomavirus-infected cervical cancer cell lines HeLa and CaSki. HeLa cells depleted of cyclin B1 exhibit mitotic defects in spindle formation and chromosome alignment. Downregulation of cyclin B1 increases p14 alternative reading frame of p16, the positive regulator of p53, and decreases phosphorylation of Ser315 in p53. Whereas RO-3306, a selective inhibitor of cyclin-dependent kinase 1 (Cdk1), suppresses this phosphorylation at Ser315 of p53, ZM447439, targeting Aurora A/B kinases, shows no effect. Further analyses in HeLa cells and HCT116 p53(?/?) cells suggest that the Ser315 phosphorylation by Cdk1 regulates negatively the protein stability and the function of p53. Moreover, increased p53 in HeLa cells is functional by showing its increased downstream effectors p21, mouse double minute 2 and Bax. Restoration of p53 and silencing cyclin B1 render cervical carcinoma cells more susceptible to DNA damage agent camptothecin. Taken together, targeting cyclin B1 might be an attractive strategy for preventing and treating papillomavirus-associated cancer by reactivating p53 and by reducing the Cdk1 activity.
机译:功能性p53的废除负责恶性细胞转化和维持人乳头瘤病毒感染的癌细胞的恶性状态。因此,p53的恢复已被认为是对抗乳头瘤病毒相关的恶性肿瘤的分子干预的重要策略。我们在这里显示耗尽细胞周期蛋白B1稳定并重新激活乳头瘤病毒感染的宫颈癌细胞HeLa和CaSki中的p53。耗尽细胞周期蛋白B1的HeLa细胞在纺锤体形成和染色体排列中显示有丝分裂缺陷。细胞周期蛋白B1的下调增加了p16的p14替代阅读框,p53的正调控子,并降低了p53中Ser315的磷酸化。而RO-3306是细胞周期蛋白依赖性激酶1(Cdk1)的选择性抑制剂,可抑制靶向Aurora A / B激酶的p53,ZM447439在Ser315的磷酸化,没有效果。在HeLa细胞和HCT116 p53(α/β)细胞中的进一步分析表明,Cdk1引起的Ser315磷酸化负调控蛋白质的稳定性和p53的功能。此外,HeLa细胞中增加的p53通过显示其增加的下游效应子p21,小鼠双分2和Bax发挥功能。 p53的恢复和细胞周期蛋白B1的沉默使宫颈癌细胞更容易受到喜树碱DNA破坏剂的影响。综上所述,靶向细胞周期蛋白B1可能是通过重新激活p53和降低Cdk1活性来预防和治疗乳头瘤病毒相关癌症的诱人策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号